FDA Requests Nominations For Do-Not-Compound List

Washington Drug Letter
A A
The FDA is building a list of difficult-to-manufacture drugs that compounders will not be allowed to make and is soliciting public suggestions for products to place on the list.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00